Aug. 09, 2013

New Vaccine Beats Malaria in Early Trials

Reporting in Science, researchers write of an intravenous vaccine that offered complete protection against malaria in a small clinical trial—but only after five doses. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, discusses steps needed to turn this early success into a practical vaccine.

Produced by Christopher Intagliata, Senior Producer

Guests

Tony FauciDirector, National Institute of Allergy and Infectious DiseasesThe National Institutes of HealthBethesda, Maryland